Dr. Katherine J. Walsh, MD

Dr. Walsh practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Walsh's NPI, 1033207451, was assigned on October 11, 2006. Dr. Walsh graduated from University Of Florida College Of Medicine in 2004. Dr. Walsh holds Tennessee license 62865.

Dr. Walsh's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Walsh's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Walsh to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Walsh practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Walsh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Walsh is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Walsh's licenses on file in 4 states: Tennessee, Ohio, North Carolina and Georgia.

Dmand AI lists anemia, chronic anemia, chronic leukemia, lung cancer, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Walsh treats.

CMS data shows 219 Medicare services from Dr. Walsh across 5 procedure codes in 2024, for 149 Medicare patients. Medicare paid $16,116 for them.

CMS counts 149 Medicare patients who saw Dr. Walsh in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Walsh's median patient age at 65, with 59% women.

In 2024, Dr. Walsh wrote 301 Medicare Part D claims for 52 patients. 50% of them were for generic drugs. CMS names the drug for 245 of them, across 9 drugs with 11 or more claims each, at $1,916,825 in total drug cost. In 2023, CMS named 172 claims across 7 drugs.

Dr. Walsh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Walsh as offering telehealth.

Dmand AI links 45 papers to Dr. Walsh, published from 2013 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Endothelium, Vascular, Fas Ligand Protein and Membrane Glycoproteins. Dr. Walsh has published most often in Am J Med. Dr. Walsh's most frequent co-authors are Alison R. Walker, MD, Bhavana Bhatnagar, DO and Ramiro Garzon, MD.

Dmand AI links Dr. Walsh to 1 clinical trial. Conditions studied include Leukemia, Myeloid, Acute and Congenital Abnormalities.

CMS Open Payments shows 8 general payments to Dr. Walsh from 5 drug and device companies from 2020 to 2025. Honoraria make up the largest share, 47% of the total. Blueprint Medicines Corporation paid the most, $4,633.

Dmand AI lists 1 award for Dr. Walsh, most recently CMS Stage 1 EHR in 2013.

Dr. Walsh graduated from University Of Florida College Of Medicine in 2004. Dr. Walsh is a member of ASCO.

Dr. Walsh is in network with 12 carriers, including Aetna, Cigna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.